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CsrA has been shown to positively control the expression of flagella-related genes,
including flaA and flaB, through regulating expression of an alternative sigma factor RpoN
in Helicobacter pylori J99. Here, we aimed to characterize the CsrA regulatory system by
comparative transcriptomic analysis carried out with RNA-seq on strain J99 and a csrA
mutant. Fifty-three genes in the csrA mutant were found to be differentially expressed
compared with the wild-type. Among CsrA-regulated genes, jhp0106, with unclear
function, was found located downstream of flaB in the J99 genome. We hypothesized
that flaB-jhp0106 is in an operon under the control of RpoN binding to the flaB promoter.
The RT-qPCR results showed the expression of jhp0106 was decreased 76 and 92% in
the csrA and rpoNmutants, respectively, compared to the wild-type. Moreover, mutations
of the RpoN binding site in the flaB promoter region resulted in decreased expression
of flaB and jhp0106 and deficient motility. Three-dimensional structure modeling results
suggested that Jhp0106 was a glycosyltransferase. The role of jhp0106 in H. pylori was
further investigated by constructing the jhp0106mutant and revertant strains. A soft-agar
motility assay and transmission electron microscope were used to determine the motility
and flagellar structure of examined strains, and the results showed the loss of motility
and flagellar structure in jhp0106 mutant J99. In conclusion, we found jhp0106, under
the control of the CsrA/RpoN regulatory system, plays a critical role in H. pylori flagella
formation.
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INTRODUCTION
Helicobacter pylori is a highly prevalent human pathogen that colonizes roughly 50% of the world’s
population. Persistent infection with H. pylori increases the risk of developing gastroduodenal
diseases, including chronic gastritis, gastric and duodenal ulcer, and gastric adenocarcinoma
(Parsonnet et al., 1991; Graham et al., 1993; Ahmad et al., 2003). Motility of H. pylori mediated
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by flagella has been shown to be critical for the cells to establish
initial colonization and achieve dense colonization and severe
pathological outcomes in patients (Eaton et al., 1996; Ottemann
and Lowenthal, 2002; Kao et al., 2012a, 2016). Despite intensive
research in the role of motility in H. pylori pathogenesis, the
complex regulatory network that modulates the expression of
flagellar genes in H. pylori is still not fully understood.
H. pylori has five to seven polar, sheathed flagella, which are
composed of three main structures: the basal body, hook and
filament (Lertsethtakarn et al., 2011). Flagellar related genes are
divided into three classes, governed by the housekeeping sigma
factor σ80 (RpoD, regulating class I genes), the alternative sigma
factors σ54 (RpoN, regulating class II genes), and σ28 (FliA,
regulating class III genes) (Niehus et al., 2004; Kao et al., 2016).
The flagellar filament consists of two flagellin proteins, FlaA (the
major constituent) and FlaB (Kostrzynska et al., 1991; Suerbaum
et al., 1993). H. pylori flagellin proteins are synthesized, then
post-translationallymodified intracellularly by glycosylation with
a nine carbon pseudaminic acid sugar derivative that resembles
sialic acid (Schirm et al., 2003; Logan, 2006). The enzymes
of the pseudaminic acid biosynthetic pathway in H. pylori, in
order, are PseB, PseC, PseH, PseG, and PseI (Schirm et al., 2003;
Menard et al., 2014), and the glycosylation process is essential
for assembly of functional flagellar filaments and consequent
bacterial motility (Schoenhofen et al., 2006).
CsrA was identified as a post-transcriptional regulator of
glycogen biosynthesis, motility, biofilm formation and bacterial
virulence in E. coli, acting as an RNA binding protein on its
target mRNA and thus affecting its stabilization or translation
(Romeo et al., 1993, 2013; Liu et al., 1995; Liu and Romeo, 1997;
Wang et al., 2005; Jonas et al., 2008). InH. pylori strain J99, CsrA
regulates flagella formation by controlling RpoN expression, and
it thereby affects bacterial motility (Kao et al., 2014). Although
the decrease of FlaA/FlaB partially explains the non-flagellated
phenotype of the csrAmutant observed by transmission electron
microscopy (TEM) (Kao et al., 2014), other regulators or
mechanisms may be involved in the CsrA regulatory system. In
this study, we aimed to characterize the CsrA regulatory system
by comparative transcriptomic analysis carried out with RNA-
seq on H. pylori strain J99 and a csrA mutant. We demonstrated
that Jhp1006, a putative glycosyltransferase involved in H. pylori
J99 flagella formation and motility, is under the control of
CsrA/RpoN.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in this study are described
in Table 1. H. pylori cells were grown on CDC anaerobic blood
agar (BBL, Microbiology Systems, Cockeysville, MD) or in
Brucella broth containing 10% (v/v) horse serum (Gibco BRL,
Life Technologies, Rockville, MD) at 37◦C in microaerophilic
conditions (5% O2, 10% CO2 and 85% N2). E. coli was grown
on Luria-Bertani (LB) (BD Biosciences, San Jose, CA) agar or
in broth. Bacteria harboring antibiotic resistance determinants
were grown in the presence of the appropriate antibiotics at
the following concentrations: ampicillin (Amp, 100µg ml−1);
chloramphenicol (Cm, 25µg ml−1 for E. coli, 10µg ml−1 for H.
pylori); kanamycin (Km, 50µgml−1 for E. coli, 10µgml−1 forH.
pylori). All strains were stored at−80◦C in Brain-Heart Infusion
(BHI) broth (H. pylori) or LB broth (E. coli) containing 20% (v/v)
glycerol until testing.
Cell Line and Cell Culture
The human gastric carcinoma cell line AGS (purchased from
ATCC; American Type Culture Collection, Manassas, VA, USA)
was grown in Ham’s F-12 medium (Invitrogen Life Technologies,
Rockville, MD) supplemented with 10% (v/v) fetal bovine serum
(Gibco BRL) in an atmosphere consisting of 5% CO2 at 37
◦C.
The human gastric epithelial immortalized GES-1 cells (a gift
from Prof. Wei-Lun Chang, National Cheng Kung University
Hospital) were grown in RPMI 1640 medium (Invitrogen Life
Technologies) supplemented with 10% (v/v) fetal bovine serum
in an atmosphere consisting of 5% CO2 at 37
◦C.
DNA Techniques
Mini Qiagen columns and a QiaAmp DNA extraction kit
(Qiagen, Valencia, CA, USA) were used for plasmid and
chromosomal DNA extraction. PCR was carried out according to
the manufacturer’s instruction using Taq polymerase (Promega,
Madison, WI, USA).
RNA-Seq Library Preparation and
Sequencing
H. pylori cells were grown on CDC plates in microaerophilic
conditions for 36 h, then transferred to 100 ml Brucella broth
containing 10% (v/v) horse serum at an optical density (OD)
of 0.2 and incubated with shaking (150 rpm, to reduce cell
aggregation) for 18 h in microaerophilic conditions. Mini
Qiagen columns and a Qiagen RNAeasy mini kit (Qiagen,
Valencia, CA) were used for RNA extraction. Ribosomal RNA
was depleted according to the manufacturer’s instruction using
Bacteria MinusTM Transcriptome Isolation Kit (Invitrogen Life
Technologies). The Applied Biosystems SOLiDTM Total RNA-
Seq kit was used to generate the cDNA template library. The
SOLiDTM EZ Bead system (Invitrogen Life Technologies) was
used to perform emulsion clonal bead amplification to generate
bead templates for SOLiDTM platform sequencing. Samples were
sequenced on the 5500XL SOLiDTM platform. The 50-base short
read sequences produced by the 5500XL SOLiDTM sequencer
were first run through SOLiD Accuracy Enhancement Tool
(SAET) to improve color call accuracy, then were mapped in
color space using SOLiDTM LifeScopeTM software version 2.5
using default parameters against the H. pylori J99 reference
genome (NCBI accession number, NC_000921). The BAM file
from LifeScopeTM was performed the analysis of gene expression
with Partek software package. The gene expression from each
sample was then tested for statistical differences using one-way
ANOVA at 5% confidence level. The complete set of RNA-seq
files has been deposited in Gene expression omnibus (GEO),
NCBI (https://www.ncbi.nlm.nih.gov/geo/, accession number
GSE95006). The fold change of each gene was measured as the
mean of three independent experiments. Gene expression of the
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TABLE 1 | Strains and plasmids used in this study.
Strain or plasmid Relevant genotype or description Reference or source
E. coli STRAIN
DH5α F−9 80dlacZ1M15 1(lacZYA-argF) U169 hsdR17 recA1 thi-1 relA1 Laboratory stock
H. pylori STRAIN
J99 Isolated from patient with duodenal ulcer; motile Alm et al., 1999
SW835 csrA mutant J99; non-motile; Cmr Kao et al., 2014
SW836 csrA revertant, derived from SW835; motile Kao et al., 2014
SW837 rpoN mutant J99; non-motile; Cmr Kao et al., 2014
SW838 rpoN revertant, derived from SW837; motile This study
SW853 Mutation of RpoN binding site of the flaB promoter (CG to AA, GG to AA) This study
SW854 Mutation of RpoN binding site of the flaB promoter (GG to AA) This study
SW855 Mutation of RpoN binding site of the flaB promoter (deletion) This study
SW856 Mutation of RpoN binding site of the flaB promoter (cat cassette insertion); Cmr This study
SW857 flaB promoter revertant, derived from SW856 This study
SW858 flaB revertant, derived from SW859 This study
SW859 flaB mutant J99 (flaB/cat in opposite direction); Cmr This study
SW860 flaB revertant, derived from SW861 This study
SW861 flaB mutant J99 (flaB/cat in same direction); Cmr This study
SW862 jhp0106 revertant, derived from SW863 This study
SW863 jhp0106 mutant J99; non-motile; Kmr This study
SW866 flaA mutant J99; non-motile; Kmr This study
SW868 flaA/flaB double mutant J99, derived from SW861; non-motile; Cmr, Kmr This study
PLASMID
pUC18 A general cloning vector with lacZ selection; Ampr Invitrogen
pMW758 pUC18 containing the rpoN fragment; Ampr Kao et al., 2014
pMW801 pUC18 containing the jhp0106 fragment; Ampr This study
pMW802 pMW801 containing a aph(3’)-III cassette inserted into the jhp0106 fragment; Ampr, Kmr This study
pMW810 pMW814 with mutations of RpoN binding site of the flaB promoter (CG to AA, GG to AA); Ampr This study
pMW811 pMW814 with mutations of RpoN binding site of the flaB promoter (GG to AA); Ampr This study
pMW812 pMW813 containing a cat cassette inserted into the flaB promoter fragment; Ampr, Cmr This study
pMW813 pMW814 containing a NaeI cutting site and 46 bp removal in the flaB promoter fragment; Ampr This study
pMW814 pUC18 containing the flaB promoter fragment; Ampr This study
pMW815 pMW817 containing a cat cassette inserted into the flaB fragment (flaB/cat in opposite direction); Ampr, Cmr This study
pMW816 pMW817 containing a cat cassette inserted into the flaB fragment (flaB/cat in same direction); Ampr, Cmr This study
pMW817 pUC18 containing the flaB fragment; Ampr This study
pMW833 pUC18 containing the flaA fragment; Ampr This study
pMW834 pMW833 containing a aph(3’)-III cassette inserted into the flaA fragment; Ampr, Kmr This study
Vector78 A vector containing cat cassette inserted in HincII site; Cmr Wang and Taylor, 1990
pBHP489k A vector containing aph(3’)-III cassette inserted in ClaI site; Kmr Lee et al., 1997
cat, chloramphenicol acetyltransferase; Ampr , ampicillin resistant; Cmr , chloramphenicol resistant; Kmr , kanamycin resistant.
csrA mutant compare to wild-type J99 with a fold change >
1.5-fold was selected and confirmed by RT-qPCR.
Preparation of cDNA from H. pylori
H. pylori cells were grown on CDC plates in microaerophilic
conditions for 36 h, then transferred to 100 ml Brucella broth
containing 10% (v/v) horse serum at an OD of 0.2 and incubated
with shaking (150 rpm) for 18 h in microaerophilic conditions.
RNA extraction and reverse transcription PCR were described
previously (Kao et al., 2012b). Thirty microliters of culture media
were centrifuged at 1,000 × g for 5 min at 4◦C and then washed
with ice-cold 0.2 M sodium acetate buffer (pH 5.5) twice. The
bacterial pellet was then re-suspended in 600µl acetate buffer
(20 mM sodium acetate, 1 mM EDTA, and 0.5% (w/v) SDS),
and 600 µl acid-phenol (pH 4.5) was added to isolate bacterial
RNA. The sample was incubated at 65◦C for 10 min, and
centrifuged at 12,000 × g for 10 min to collect the supernatant.
After isopropanol precipitation, the sample was treated with
DNase I (Promega) at 37◦C for 2 h. Finally, phenol/chloroform
was used to extract total RNA, and the sample was dissolved
in diethylpyrocarbonate (DEPC)-treated deionized water and
stored at −80◦C until used. The RNA was quantified at an
absorbance of 260 nm. Random hexamers (Mission biotech,
Taiwan) and MMLV reverse transcriptase (Promega) were used
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to generate cDNA from 1 µg of total RNA, and the cDNA was
stored at−20◦C until testing.
Real-Time Quantitative RT-PCR (RT-qPCR)
The primers used for RT-qPCR are listed in Table S1. RNA
quantification was carried out by RT-qPCR with a KAPA PROBE
FAST Universal 2 x qPCR Master Mix (KAPA Biosystems Inc.,
Woburn, MA) specifically adapted for one-step RT-qPCR in glass
capillaries using a Light Cycler instrument (Roche Diagnostics,
Indianapolis, IN). Cycling conditions were as follows: activation
of the polymerase for 10 min at 95◦C, followed by 40 cycles of
denaturation at 95◦C for 20 s, annealing at 60◦C for 1min, and
elongation at 72◦C for 15 s. Fluorescence was detected at the end
of each extension step, and the Cp values were calculated by the
LightCycler 1.5 software.
Construction of the Mutants and
Revertants
The primers used in this study are listed in Table S1. In order
to construct a revertant strain from rpoN mutant J99 (SW837),
the plasmid containing the rpoN fragment, pMW758 (Kao et al.,
2014), was transformed into SW837 to generate a revertant
strain containing the wild-type rpoN. In brief, after natural
transformation (Haas et al., 1993), H. pylori was grown on CDC
anaerobic blood agar without antibiotic for 3 days. Colonies were
picked and subcultured on CDC anaerobic blood agar without
antibiotic and Brucella agar plate containing 10% (v/v) horse
serum and Cm (10µg ml−1) at the same time and incubated
at 37◦C in microaerophilic conditions for 3 days. Colonies that
lost the ability to grow on a Cm-containing plate (that only grew
on CDC anaerobic blood agar) were considered as the revertant
strain and were verified by PCR-sequencing and motility assay.
For flaB mutant construction, the 1,175 bp flaB fragment
obtained from H. pylori J99 genomic DNA and PCR with
flaB-Mut-1 and flaB-Mut-2 primers, was digested by PstI and
KpnI and ligated to the plasmid pUC18 to generate plasmid
pMW817. A chloramphenicol acetyltransferase cassette (cat
cassette) containing 806 bp was obtained from plasmid vector
78, cut with HincII and inserted into plasmid pMW817 digested
with HincII. Two plasmids were designated as plasmid pMW815
(flaB/cat in opposite transcriptional orientation) and pMW816
(flaB/cat in same transcriptional orientation), respectively, and
transformed into J99. Cm (10 µg ml−1) was used to select for the
flaB mutants, SW859 and SW861, generated from chromosomal
flaB double cross-over with plasmids pMW815 and pMW816,
respectively. Plasmid pMW817 was then transformed into
SW859 and SW861 to generate a revertant strains SW858 and
SW860, respectively.
For jhp0106 mutant construction, the 1,004 bp jhp0106
fragment, obtained from J99 genomic DNA and PCR with
jhp0106-Mut-1 and jhp0106-Mut-2 primers, was digested with
EcoRI and ligated into the plasmid pUC18 to generate plasmid
pMW801. A kanamycin resistance cassette (aph(3′)-III cassette)
was obtained from plasmid vector pBHP489K, cut with ClaI and
inserted into the plasmid pMW801 digested with BsmI. This
plasmid was designated as plasmid pMW802 and transformed
into J99. Km (10µg ml−1) was used to select for the jhp0106
mutant, SW863. In order to construct a jhp0106 revertant from
SW863, the plasmid pMW801, was transformed into SW863 to
generate SW862 containing wild-type jhp0106.
For flaA and flaA/flaB mutants construction, the 1,283 bp
flaA fragment obtained from H. pylori J99 genomic DNA and
PCR with FlaA-Mut-1 and FlaA-Mut-2 primers, was digested
by PstI and KpnI and ligated to the plasmid pUC18 to generate
plasmid pMW833. A aph(3′)-III cassette obtained from plasmid
vector pBHP489K was inserted into plasmid pMW833 digested
with AfeI. This plasmid was designated as plasmid pMW834 and
transformed into J99 and SW861 (flaBmutant). Km (10µgml−1)
was used to select for the flaA mutant (SW866) and flaA/flaB
double mutant (SW868).
Construction of the flaB Promoter Mutants
and Revertant
The primers used for construction of the flaB promoter mutants
and revertant are listed in Table S1. The 1,001 bp flaB promoter
fragment obtained from H. pylori J99 genomic DNA and PCR
with flaB-ProMut-1 and flaB-ProMut-2 primers, was digested
by HincII and EcoRV and ligated to the plasmid pUC18 to
generate plasmid pMW814. Primers flaB-ProMut-3 and flaB-
ProMut-4 were used to amplify pMW814 to generate plasmid
pMW813 containing a 46 bp partial deletion of the flaB promoter
and carrying a NaeI site in the flaB promoter fragment. A
cat cassette obtained from plasmid vector 78 was inserted
into plasmid pMW813 digested with NaeI. This plasmid was
designated as plasmid pMW812 and transformed into J99.
Cm was used to select for the flaB promoter-cat mutant,
SW856. In order to construct flaB promoter mutants with GG
or CG/GG nucleotide mutations, primer pairs flaB-ProMut-
7/flaB-ProMut-8 and flaB-ProMut-9/flaB-ProMut-10 were used
to amplify pMW814 to generate plasmid pMW811 and pMW810,
respectively. pMW814, pMW813, pMW811, and pMW810 were
transformed into SW856 to generate SW857 (revertant), SW855
(deletion), SW853 (CG to AA/GG to AA), and SW854 (GG to
AA), respectively.
Soft-Agar Motility Assay
The motility assay was described previously (Kao et al., 2014).
Bacterial colonies were applied to one spot in the motility agar
plate containing Brucella broth, 0.3% (w/v) Bacto agar, and
supplemented with 10% (v/v) horse serum. The plates were
incubated at 37◦C under microaerophilic conditions for 7 days,
and the motility was assessed by the diameter of migration of
bacteria through the agar, from the inoculated center toward the
periphery of the plate. The motility of each strain was measured
as the mean of three independent experiments.
Reconstruction of Three-Dimensional
Model of Jhp0106 Protein
Complete amino acid sequence of H. pylori J99 Jhp0106
(Accession number: WP_001028953) was downloaded from
NCBI database (http://www.ncbi.nlm.nih.gov/protein/). A three-
dimensional structural modeling was carried out on the SWISS-
MODEL Workspace server (http://swissmodel.expasy.org/)
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(Arnold et al., 2006). The structure representation figures are
generated by the program PyMOL (http://www.pymol.org).
Transmission Electron Microscope
A grid covered with a carbon-coated parlodion film (300 mesh
copper grid) was floated onto a 20 µl sample drop and left for
2 min for adsorption of the sample to the grid. The grid was
then removed from the drop and floated on a drop of 1% (w/v)
phosphotungstic acid (Sigma-Aldrich) and left for 1min. Excess
stain was removed by touching the edge of the grid to a piece of
Whatman filter paper. All samples for electron microscopy were
examined in a Hitachi H-7650 transmission electron microscope
(Hitachi, Tokyo, Japan).
Bacterial Adhesion and IL-8 Production
Assay
The assay was performed according to a previous study with
modification (Kwok et al., 2002). AGS and GES-1 cells (1 ×
106/well) were grown overnight in 6-well culture dishes to
approximately 80% confluence. H. pylori cells were added to
the wells at a multiplicity of infection (MOI) of 100 without
centrifugation and were incubated for either 30 min for the
adhesion assay or 8 h for the cellular IL-8 production assay. For
the adhesion assay, each dish with AGS-H. pylori coculture was
washed three times with prewarmed phosphate-buffered saline
(PBS) buffer to remove unbound bacteria. AdheredH. pyloriwere
quantified by lysing the cells for 15 min with 0.1% (w/v) saponin-
containing PBS buffer, followed by serial dilution and spreading
on Brucella agar plates containing 10% (v/v) horse serum.
The number of adhered bacteria was measured by the plate
counts after 3 days incubation. For the cellular IL-8 production
assay, the culture supernatants were collected and stored at
−20◦C until assayed. IL-8 concentration in the supernatant
was determined by standard ELISA with commercially available
assay kits according to the manufacturer’s procedures (Arigo
Biolaboratories Corp., Taiwan).
Statistics
The Student’s t-test and paired t-tests were applied as appropriate
for the parametric differences. ANOVA was used for comparing
groups of more than two strains. All tests of significance were
two-tailed with a p value< 0.05 taken as significant.
RESULTS
CsrA Acts as a Global Positive Regulator in
Strain J99
To characterize the CsrA regulatory system, RNA-seq analysis
on the wild-type J99 and its respective csrA mutant, SW835,
was carried out. Three independent biological replicates were
sequenced for each strain. The raw sequence output of the two
strain transcriptomes included∼14 and∼15 million reads of the
wild-type and csrA mutant, respectively. Approximately 80% of
the reads were perfectly aligned to the J99 reference genome.
Based on the genomic alignment, our analysis determined the
expression of 1,559 genes in each strain.
In this study, genes found to be differentially expressed
compared to the wild-type J99 (a > 1.5-fold change) by RNA-
seq data were taken into consideration. In the csrA mutant, 53
chromosomally encoded genes were found to be differentially
expressed compared to the wild-type J99 (Table 2). Of these
genes, 94% (50 genes) were expressed at a lower level in the csrA
mutant compared to the wild-type, with only 6% (3 genes) having
higher expression in the csrA mutant (Table 2). These results
indicate that CsrA acts primarily as a global positive regulator.
RT-qPCR was further employed to validate the expression of 53
CsrA regulated genes in the wild-type and csrAmutant (Table 2).
In agreement with the RNA-seq data, RT-qPCR confirmed
the expression of genes differentially expressed in the csrA
mutant compared to the wild-type J99 with a > 2-fold change
(except jhp1296). Three genes, jhp1334, jhp1169 and jhp1132,
originally identified with a>1.5-fold change by RNA-seq, showed
inconsistent results between the RNA-seq and RT-qPCRmethods
(change <1.5-fold by RT-qPCR) (Table 2). These transcriptomic
analyses also indicated that most of CsrA regulated genes (18
genes) were classified as genes encoding components involved
in flagella formation, chemotaxis and motility, followed by genes
with unknown function (15 genes) (Figure S1).
CsrA/RpoN Regulates flaB-jhp0106
Expression
The CsrA-regulated jhp0106 gene was of interest, as it encodes a
protein suggested to be involved in H. pylori strain 1016 flagellin
glycosylation and motility (Schirm et al., 2003) (Table 3). The
schematic diagram showing the pseudaminic acid biosynthetic
pathway in H. pylori is shown in Figure S2. At present, the
function of Jhp0106 in flagellin glycosylation is still unclear.
We validated the transcription of pseB, pseC, pseH, pseG, pseI
and jhp0106 in the wild-type, SW835 (csrA mutant) and SW836
(csrA revertant) strains by RT-qPCR. The results were consistent
with the RNA-seq data. Only the expression of jhp0106 was
dramatically reduced in SW835 compared to the wild-type J99
(Figure S3).
The genes close to jhp0106 in H. pylori J99 are shown in
Figure 1A. jhp0106 was located immediately downstream of the
flaB gene, which has been shown to be regulated by RpoN.
The gene order and orientation of flaB-jhp0106 are conserved
in H. pylori genomes. Therefore, we propose genes flaB and
jhp0106 are in an operon controlled by RpoN binding to the
flaB promoter. To validate this hypothesis, RT-qPCR was carried
out to determine the expression of rpoN and jhp0106 in the
wild-type, SW835 (csrAmutant), SW836 (csrA revertant), SW837
(rpoN mutant), and SW838 (rpoN revertant) strains. The results
showed that the expression of rpoN was reduced in SW835
(Figure 1B), consistent with our previous study (Kao et al., 2014).
Moreover, expression of jhp0106 mRNA was decreased to 24
and 8% in SW835 and SW837, respectively (p < 0.001). These
results indicated that CsrA and RpoN positively regulate jhp0106
expression.
RT-PCR with different primer pairs was performed to confirm
the co-transcription of flaB-jhp0106, and the results showed that
1.4- and 1.8-Kb transcripts were observed using primer pairs
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TABLE 2 | Gene ID, annotation and function of genes regulated by the CsrA regulatory system identified by RNA-seq analysis
Gene ID (J99) Gene ID (26695) Annotation Fold change (RNA-Seq/RTqPCR)a
METABOLISM
jhp0099 (cysK) HP0107 Cysteine synthase −2.05**/−2.27
jhp0158 (moeA) HP0172 Molybdopterin biosynthesis protein −1.57**/−1.62
jhp0338 (ribF ) HP1087 Riboflavin kinase −3.44***/−2.39
jhp0528 (pyrC_2) HP0581 Dihydroorotase −3.57***/−2.98
jhp1334 (ppiA) HP1441 Peptidyl-prolyl cis-trans isomerase −1.80***/−1.09
NUCLEOTIDE METABOLISM
jhp0549 HP0602 3-methyladenine DNA glycosylase −1.61*/−2.05
jhp0691 HP0754 5-formyltetrahydrofolate cyclo-ligase −4.19***/−4.97
jhp1050 HP1121 DNA methyltransferase −3.80***/−2.95
jhp1296 –b Type II restriction endonuclease −2.56**/−1.27
CHEMOTAXIS AND MOTILITY
jhp0106 HP0114 Unclear −3.70**/−4.37
jhp0107 (flaB) HP0115 Flagellin B −3.99***/−3.04
jhp0280 (flgL) HP0295 Flagellar hook-associated protein 3 (HAP3) −3.66**/−4.20
jhp0349 HP1076 Cochaperone −8.13***/−6.26
jhp0374 HP1051 Unclear −2.74***/−2.20
jhp0548 (flaA) HP0601 Flagellin A −2.94***/−2.73
jhp0688 (flaG) HP0751 Putative flagellin protein −4.38***/−3.32
jhp0689 (fliD) HP0752 Putative flagellar hook-associated protein 2 (HAP2) −4.76***/−4.09
jhp0690 (fliS) HP0753 Putative flagellar protein −5.12***/−5.23
jhp0751 (motA) HP0815 Flagellar motor protein −1.53**/−3.07
jhp0752 (motB) HP0816 Flagellar motor protein −1.67***/−1.93
jhp0804 (flgE) HP0870 Flagellar hook protein −1.52*/−7.32
jhp0842 HP0906 FliK functional homolog −3.24**/−2.50
jhp1047 (flgK) HP1119 Flagellar hook-associated protein 1 (HAP1) −4.88***/−3.28
jhp1048 HP1120 Unclear −4.95***/−3.96
jhp1051 (flgM) HP1122 Sigma-28 factor antagonist −3.24***/−3.14
jhp1154 HP1233 Unclear −1.83*/−1.66
jhp1169 HP1248 Ribonuclease II family protein −1.61***/−1.46
REGULATOR
jhp0652 (rpoN) HP0714 RNA polymerase sigma-54 factor −3.09***/−3.18
TRANSPORT
jhp0167 HP0179 ABC transporter, ATP-binding protein −1.60**/−5.59
jhp0396 HP1028 Lipocalin family protein −2.06**/−2.28
jhp0529 (tonB) HP0582 Siderophore-mediated iron transport protein −3.22***/−3.24
jhp0653 HP0715 ABC transporter, ATP-binding protein −3.22***/−3.72
jhp0743 (fecA) HP0807 Iron (III) dicitrate transport protein −1.75ns/−3.37
CELL SURFACE STRUCTURE
jhp0373 (lpxC) HP1052 UDP-3-O-hydroxymyristoyl −2.72***/−2.31
jhp0424 HP0472 Outer membrane protein (omp11) −5.06***/−4.49
jhp0526 HP0579 Kdo hydrolase subunit 2 −4.01**/−2.64
jhp0527 HP0580 Kdo hydrolase subunit 2 −3.03***/−2.04
STRESS RESPONSE
jhp0423 (kefB) HP0471 Glutathione-regulated potassium efflux system protein −2.23***/−3.00
PUTATIVE OR UNKNOWN FUNCTION
jhp0436 HP0484 Putative −3.38***/−2.45
jhp0550 HP0603 Putative −2.17***/−2.24
jhp0572 HP0629 Putative 1.54*/3.54
jhp0753 HP0817 Putative −1.54***/−1.69
(Continued)
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TABLE 2 | Continued
Gene ID (J99) Gene ID (26695) Annotation Fold change (RNA-Seq/RTqPCR)a
jhp0936 –b Putative −1.78***/−3.24
jhp1049 –b Putative −3.53***/−2.94
jhp1242 HP1322 Putative 2.60**/2.48
jhp1302 HP1409 Putative 2.83ns/2.70
jhp1332 HP1439 Putative −1.85ns/−1.23
jhp1333 HP1440 Putative −7.22***/−11.63
jhp1430 HP1397 Putative −3.23***/−2.97
jhp1431 HP1396 Putative −3.74***/−4.12
jhp1436 HP1391 Putative −2.16**/−2.13
jhp1437 –b HcpA family protein −1.63**/−1.69
jhp1474 HP1566 Membrane protein −1.77***/−1.88
aGene expression in the csrA mutant compare to wild-type J99 with a change > 1.5-fold is listed in this table. ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
bStrain-specific genes in H. pylori J99.
TABLE 3 | Proteins showing high similarity to Jhp0106.
Bacteria Protein Function a.a (no.) Identities to Jhp0106 (%) References
Calditerrivibrio nitroreducens Calni_0724 Unclear 633 30 –
Campylobacter jejuni Cj1340c Motility accessory factor 605 30 Golden and Acheson, 2002
Campylobacter jejuni Maf1 Motility accessory factor 649 35 Karlyshev et al., 2002
Campylobacter jejuni Maf3 Motility accessory factor 619 34 McNally et al., 2006
Campylobacter jejuni Maf4 Flagellin glycosylation 649 35 van Alphen et al., 2008
Campylobacter jejuni Maf6 Motility accessory factor 607 29 Karlyshev et al., 2002
Campylobacter jejuni PseD Flagellin glycosylation 653 36 McNally et al., 2006
Campylobacter jejuni PseE Flagellin glycosylation 628 34 McNally et al., 2006
Caminibacter mediatlanticus CMTB2_07872 Unclear 631 41 –
Denitrovibrio acetiphilus Dacet_0453 Unclear 633 29 –
Helicobacter mustelae HMU07160 Unclear 629 62 –
Helicobacter pylori Jhp0106 Motility accessory factor 627 100 Schirm et al., 2003
Nautilia profundicola NAMH_1610 Motility accessory factor 643 44 –
Sulfurospirillum deleyianum Sdel_2228 Unclear 627 42 –
Syntrophomonas wolfei Swol_0199 Unclear 671 28 –
jhp0106-1/flaB-4 and jhp0106-3/flaB-4 for RT-PCR, respectively
(Figure 2A). In addition, the expression of the flaB-jhp0106
transcript was reduced in SW837 (Figure 2A). The predicted
RpoN binding site of the flaB promoter was examined by
construction of flaB promoter mutants, as shown in Figure 2B.
The mRNA levels of flaB and jhp0106 were dramatically
reduced in SW837, SW853, SW854, SW855, and SW856, as
determined by RT-qPCR (Figure 2C). We further investigated
whether the RpoN binding site of the flaB promoter was
conserved among different H. pylori strains, and the results
showed that the RpoN binding sequence was identical among
17 examined strains (Figure S4). Our results indicated the
transcription of jhp0106 is positively controlled by RpoN bound
to the flaB promoter. However, these results could not exclude
the possibility that the jhp0106 gene had its own promoter.
Therefore, northern blotting was performed to determine the
size and number of jhp0106 transcripts. Although several
different fragments of the jhp0106 gene were used to serve as
probes, the signal was still too weak to be detectable (data not
shown).
In order to clarify the role of the flaB-jhp0106 operon in
H. pylori J99 motility, soft-agar analysis was used to determine
the motility of flaB promoter mutants (Figure 2D). SW837 was
used as a non-motile negative control. The results showed that
strains SW853, SW854, SW855, and SW856 exhibited deficient
motility (Figure 2D). These results indicated that the flaB-
jhp0106 operon was controlled by RpoN, and that it plays a
critical role in H. pylorimotility.
Jhp0106, but Not FlaB, Plays a Critical Role
in H. pylori Motility
Josenhans et al. reported that when the flaB gene was disrupted
in H. pylori strain N6, the motility decreased by 30 to
40% (Josenhans et al., 1995). To validate this observation in
strain J99, we constructed flaB mutants SW861 and SW859
(Figure 3A). A cat cassette was inserted in the same (SW861)
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FIGURE 1 | Reduced expression of jhp0106 in strains SW835 and SW837. (A) Schematic diagram showing the genetic loci of genes close to the putative
flaB-jhp0106 operon. A predicted RpoN binding site located upstream of the flaB ORF (−37 bp) is indicated. (B) RT-qPCR was used for quantifying the mRNA levels
of rpoN (left panel) and jhp0106 (right panel) in examined strains. Results are representative of 3 independent experiments (means ± SD). ***p < 0.001, ns, not
significant (vs. wild-type J99). SW835, csrA mutant; SW836, csrA revertant; SW837, rpoN mutant; SW838, rpoN revertant.
or opposite (SW859) direction to flaB transcription in wild-type
J99 (Figure 3A). Strain SW861 showed decreased motility, and
the quantified results revealed 83.8% motility ability compared
with wild-type J99 (p < 0.05) (Figure 3B). In contrast, strain
SW859 showed a non-motile phenotype, compared with the
wild-type J99 (Figure 3B). To evaluate whether the deficient
phenotype of SW859 was caused by the insertion of the cat
cassette into the flaB gene, which interfered with downstream
jhp0106 expression, RT-qPCR was performed to determine the
expression of jhp0106 in the examined strains. The results
showed that the transcription level of jhp0106 was decreased to
13% in SW859, but increased to 242% in SW861, compared to
the wild-type (Figure 3C). The increase of jhp0106 expression
in SW861 resulted from a cat cassette inserted into flaB in same
transcriptional orientation. Thus triggering downstream jhp0106
transcription due to the leakage of the transcriptional terminator
of the cat cassette. These results indicated that jhp0106 in flaB-
jhp0106 operon, but not flaB, plays a critical role in H. pylori
motility.
Jhp0106, a Putative Glycosyltransferase
The NCBI protein database was used to search for proteins
showing high similarity to Jhp0106, and the results are shown
in Table 3. Among them, HMU07160 (62%) showed the highest
identity to Jhp0106, followed by WS2199 (55%), NAMH_1610
(44%), Sdel_2228 (42%), and CMTB2_07872 (41%) (Table 3).
The phylogenic tree based on the homologous full-length
sequence of 16 proteins was also displayed in Figure S5. Previous
studies reported that Maf4, PseD and PseE were involved in
flagellin glycosylation in C. jejuni (McNally et al., 2006; van
Alphen et al., 2008), and they also displayed high identity to
Jhp0106 (Table 3).
The attempt to determine the crystal structure of Jhp0106
was unsuccessful, in spite of extensive efforts to crystallize the
recombinant Jhp0106 protein from an E. coli expression system.
Therefore, we performed computational modeling of the Jhp0106
protein to gain structural insights into Jhp0106 function. A 3D-
model for Jhp0106 of 227 amino acid residues in length (from
Asp231 to Phe457) predicted by the SWISS-MODEL server is
shown in Figure 4A. The overall folding of the Jhp0106 structure
is similar to an alpha-2,3/8-sialyltransferase CstII from C. jejuni
in complex with a substrate analog, CMP-3FNeuAc (PDB:
1R07) (Figure 4B) (Chiu et al., 2004), suggesting Jhp0106 is a
glycotransferase.
The protein interaction networks for Jhp0106 showed that
the protein interacts with flagella structure proteins (FlaA, FlaB,
FlaG, FlaL, FliD), pseudaminic acid synthase (NeuB), CagDelta
protein (Jhp0417), hypothetical proteins (PdP, Jhp0578), and
a septum formation inhibitor (MinC) (Figure S6). These
results suggested that Jhp0106 functions as a glycosyltransferase
and is involved in the transfer of pseudaminic acid to
flagellin.
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FIGURE 2 | Characterization of the flaB-jhp0106 operon. (A) The expression of the flaB-jhp0106 co-transcript in J99, SW837, and SW838 was determine by
RT-PCR. The primer pairs and predicted PCR product size are described in the lower panel. J99 DNA was considered as a positive control. Marker, GeneRulerTM
DNA ladder (Fermentas). (B) Sequence alignment of the flaB promoter region (−33 to −92 bp, upstream of the flaB ORF) of wild-type, SW855, SW854, SW853, and
SW857 strains. (C) mRNA levels of flaB and jhp0106 in 8 examined strains were measured by RT-qPCR. Results are representative of 3 independent experiments
(means ± SD). ***p < 0.001, ns, not significant (vs. wild-type J99). (D) The motility of 8 tested strains was determined by soft-agar motility assay plates. SW837 was
used as a negative control (non-motile phenotype). SW837, rpoN mutant; SW838, rpoN revertant.
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FIGURE 3 | Characterization of the influence of flaB and jhp0106 on H.
pylori motility. (A) Schematic diagram showing the construction strategy of
the flaB mutants, SW861 and SW859. (B) The quantified motility diameter of 7
examined strains. SW837 was used as a negative control (non-motile
phenotype). (C) The mRNA level of jhp0106 was determined by RT-qPCR.
Results are representative of 3 independent experiments (means ± SD). *p <
0.05, ***p < 0.001, ns, not significant (vs. wild-type J99). SW837, rpoN
mutant; SW838, rpoN revertant.
Jhp0106 Is Involved in Flagella Formation
The roles of Jhp0106 in H. pylori flagella formation, adhesion
and cellular cytokine induction were examined by constructing
jhp0106 mutant (SW863) and revertant J99 (SW862) strains.
The genetic loci of jhp0105 and flaB are close to jhp0106 in the
J99 genome (Figure 1A). In order to rule out the possibility of
polar effects in SW862 and SW863, the expression of jhp0105,
jhp0106 and flaB were determined by RT-PCR (Figure S7). The
data revealed that the mRNA expression levels of jhp0105 and
flaB in strains SW863 and SW862 were similar to J99, and the
transcription of jhp0106 was only disrupted in SW863 (Figure
S7). In addition, the 72 h growth curves of SW863 and SW862
were similar to that of the wild-type J99 (Figure S8).
The deficient motility of SW863 is shown in Figure 5A.
The bacterial shape and flagellar structure of J99, SW837,
SW838, SW862, and SW863 were examined by TEM with
negative staining. No flagellar structure was detected in SW837
and SW863, whereas the characteristic multiple polar, sheathed
flagella were abundant on J99, SW838 and SW862 (Figure 5B).
In addition, there was no dramatic difference in shape
between the strains examined. These observations demonstrated
that flagella formation was severely defective in the jhp0106
mutant.
To determine the role of flagella structure and Jhp0106 in
H. pylori pathogenesis, the adhesion rate of the bacteria and
the IL-8 production in H. pylori-infected AGS and GES-1 cells
were determined (Figure 5C and Figure S9). The results showed
that only SW868 (flaA/flaB double mutant) had lower adhesion
to AGS cells, compared with J99 (p < 0.05) (Figure 5C). No
difference in IL-8 production was observed between cells infected
with the six examined strains, as determined by an ELISA assay
(p> 0.05) (Figure S9).
Characterization of Jhp0106 in Clinical
Isolates
Many studies suggest that genetic diversity in H. pylori virulence
factors such as sabA, babA, cagA, and vacA genes is high
among isolates from different geographic regions, and may be
associated with different pathological outcomes (van Doorn
et al., 1998; Yamaoka et al., 2006). As a result, we evaluated
the prevalence of the jhp0106 gene in 95 isolates from patients
with different diseases by PCR, including 38 gastritis strains,
21 duodenal ulcer strains, 17 gastric ulcer strains, 18 gastric
cancer strains, and 1 MALToma strain. The results showed that
all tested isolates contained the jhp0106 gene. To determine
whether Jhp0106 is a critical factor in H. pylori motility among
different strains, we constructed rpoN and jhp0106 mutants of
14 clinical isolates. The results of soft-agar motility assay showed
that all rpoN mutants and jhp0106 mutants were non-motile
(Figure 6).
DISCUSSION
The present study aimed to reveal the CsrA regulatory system
by using RNA-seq, and to identify CsrA target genes involved in
H. pylori motility. We showed that CsrA regulated the level of
the flaB-jhp0106 transcript in J99 by controlling the expression
of the alternative sigma factor RpoN. In addition, Jhp0106
was characterized as a putative glycosyltransferase involved in
flagellin glycosylation and flagella formation.
Edwards et al. identified > 700 transcripts that bind to CsrA
in E. coli, indicating that CsrA affects expression of ∼15% of
the genes in E. coli (Edwards et al., 2011). In this study, we
revealed that 53 genes (∼4%) in a csrA mutant were found to be
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FIGURE 4 | Computational structure model of Jhp0106 from H. pylori J99. (A) The structural model of Jhp0106 composed of 227 amino acids, by the
SWISS-MODEL server. (B) Structural superimposition of Jhp0106 (cyan) with the crystal structure of sialyltransferase CstII in complex with CMP-3FNeuAc (PDB 1R07)
(magenta).
differentially expressed, compared to the wild-type J99 (Table 2).
Like CsrA in E. coli and Clostridium acetobutylicum (Edwards
et al., 2011; Tan et al., 2015), RNA-seq analysis showed that
CsrA in H. pylori was closely involved in regulating multiple
pathways including metabolism, iron uptake, flagella assembly,
and oligopeptide transport (Table 2). However, the molecular
mechanism through which CsrA regulates target gene expression
in strain J99 remained to be clarified. Moreover, 15 CsrA-
regulated genes of unknown function are worth investigating
further (Table 2).
CsrA has been shown to control target gene expression by
diverse mechanisms in several organisms (Romeo et al., 2013).
For example, CsrA is mainly known for its post-transcriptional
role in mRNA stability (Liu et al., 1995; Wei et al., 2001; Baker
et al., 2002; Wang et al., 2005; Esquerre et al., 2016). In other
cases, CsrA binds to multiple sites in the untranslated leader
and/or initially translated region of target transcripts, and bound
CsrA thus repressed translation by competing with ribosome
binding to the Shine-Dalgarno sequence, but did not affect the
level of targeted mRNA (Dubey et al., 2003; Ren et al., 2014).
This may explain why only 4% of genes in J99 were identified
to be regulated by CsrA, while 15% of genes were CsrA-regulated
in E. coli (Edwards et al., 2011). As a result, it is worth carrying
out a comparative proteomic analysis to evaluate any CsrA post-
transcriptionally regulated genes in H. pylori.
Barnard et al. showed that the morphology of the csrAmutant
N6 strain was similar to the wild-type strain, with a unipolar
bundle of four or five flagella (Barnard et al., 2004). mRNA levels
of flaA and flaB were elevated in the csrA mutant compared to
the N6 strain. In addition, mutation of csrA in the N6 strain
resulted in the increased expression of neutrophil activating
protein (napA), ferric uptake regulator (fur), hspR, and groESL
(Barnard et al., 2004). However, this is in contrast to our results.
The expression of flaA and flaB at the mRNA level was reduced
in the csrA mutant J99 (Table 2). napA, fur, hspR, and groESL
transcripts were not changed in the csrA mutant J99. These
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FIGURE 5 | Motility, flagellar structure, and adhesion ability of strains J99, SW837, SW838, SW863, and SW862. (A) The quantified motility diameter of
tested strains. SW837 was used as a negative control (non-motile phenotype). (B) Transmission electron micrographs of negatively stained H. pylori. Black
arrowheads indicate the presence of full-length flagella at the cell poles. Scale bars represent 500 nm. (C) The adhesion of H. pylori to AGS cells (left panel) and
GES-1 cells (right panel) with MOI 100 of the tested strains. Results are representative of 3 independent experiments (means ± SD). *p < 0.05, ***p < 0.001, ns, not
significant (vs. wild-type J99). SW837, rpoN mutant; SW838, rpoN revertant; SW863, jhp0106 mutant; SW862, jhp0106 revertant; SW866, flaA mutant; SW861, flaB
mutant; SW868, flaA/flaB mutant.
results raised the possibility that the CsrA regulatory system was
strain-specific, due to the high variation of the H. pylori genome.
Douillard et al. indicated that the hp0256 mutant has lower
motility, significantly weaker adhesion, and induces weaker IL-8
secretion in AGS cells compared to the wild-type CCUG17874
strain (Douillard et al., 2010). In our previous study, we showed
that in patients infected with higher-motility strains, the bacterial
density, inflammatory score, and rate of atrophy were higher
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FIGURE 6 | rpoN and jhp0106 are critical for the motility of 15 H. pylori strains. Wild-type, rpoN mutant, and jhp0106 mutant strains were inoculated in the
middle, left, and right of the soft-agar plate, respectively. G, gastritis; GU, gastric ulcer; DU, duodenal ulcer; GC, gastric cancer.
than those of patients infected with lower motility strains (Kao
et al., 2012a), suggesting that H. pylorimotility may be positively
correlated with bacterial adhesion and il-8 gene expression in
H. pylori-infected AGS cells. However, the jhp0106 mutation
caused a non-flagellated phenotype in strain J99, and there
was no decrease of adhesion or IL-8 production in AGS and
GES-1 cells infected with SW863, compared to the wild-type
(Figure 5, Figure S9). In contrast, the flaA/flaB double mutant
(SW868), showing deficient motility, had weaker adhesion to
AGS cells (67% compared to the wild-type) (Figure 5C). These
results indicated that the motility of J99 has a minor role
in cell adhesion. However, whether Jhp0106 modulates the
composition/or modification of surface proteins in J99 and thus
affects adhesion to AGS-1 cells is still unclear.
Based on the computational modeling, the overall structure
of Jhp0106 resembles CstII, which is reported to participate
in the sialylation of lipooligosaccharide cores and thus affects
the immunogenicity of C. jejuni (Guerry et al., 2000; Chiu
et al., 2004). Ram et al. showed that the sialylation of
gonococcal lipo-oligosaccharide enables Neisseria gonorrhoeae
to bind the alternative pathway complement inhibitor, factor
H, and thus provides a protective barrier to evade attack by
human complement (Ram et al., 1998). However, the role of
pseudaminic acid in bacterial pathogenesis remains unclear.
Pseudaminic acid has been shown to have striking structural
and biosynthetic similarities to sialic acid (Lewis et al., 2009).
Taken together, we suggested that Jhp0106 is involved in the
transfer of pseudaminic acid to flagellin FlaA/FlaB, but not in the
pseudaminic acid biosynthetic pathway (Figure S2). Therefore,
large-scale identification of Jhp0106 target proteins by an LC/MS-
based glycoproteomic approach is worth investigating.
The current treatments forH. pylori eradication are numerous
and include triple and quadruple therapy, both of which
utilize two antibiotics (metronidazole, amoxicillin, tetracycline,
or clarithromycin) in addition to either a proton pump inhibitor
(PPI) (triple therapy), or a PPI and bismuth (quadruple therapy)
(O’Connor et al., 2016). The efficacies of these therapy strategies
have been severely hampered in recent years due to the rise in
antibiotic resistance of H. pylori isolates worldwide. Therefore,
there is an emergent need to develop alternative therapeutic
strategies for the management of H. pylori infection. Currently,
carbohydrate-based therapies and diagnostics in cancer research
and infectious disease have received considerable attention.
Menard et al. identified three inhibitors of the pseudaminic
acid biosynthetic enzymes which show activity in inhibiting the
flagellin proteins on the C. jejuni cell surface, by bacterial cell-
based assays (Menard et al., 2014). In this study, we found the
prevalence of the jhp0106 gene among 95 clinical isolates of H.
pylori in Taiwan was 100%. Moreover, mutation of jhp0106 of
15 clinical strains (include J99) led to the loss of motility of
all mutants (Figure 6). These results suggest that Jhp0106 is a
promising target for developing an inhibitor to restrain H. pylori
infection in the future.
CsrA controls flagella-related genes’ expression and motility
of J99 by regulating RpoN expression (Kao et al., 2014)
(Figure 7). Although RpoN is the key regulator under the control
of CsrA, the mechanism(s) through which CsrA modulates
rpoN expression is still unclear (Figure 7). In this study, we
reveal the CsrA regulatory system in H. pylori by large-
scale identification of target genes using RNA-seq. Moreover,
the results suggest that RpoN not only controls flagellin
expression but also modulates flagella assembly by regulating
the expression of the putative glycosyltransferase Jhp0106,
and thus affects the post-translational modification of flagellin
(Figure 7). The motility of H. pylori is a critical virulence
determinant in bacterial pathogenesis, therefore, understanding
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FIGURE 7 | Current model of the CsrA/RpoN flagellar biosynthesis and motility regulatory system in H. pylori J99. Three different classes of flagellar genes
are governed by the housekeeping sigma factor RpoD (class I), and the alternative sigma factors RpoN (class II) and FliA (class III). CsrA positively controls H. pylori
J99 flagella formation and motility through regulating rpoN expression by an unclear mechanism(s) (shown in dotted line). In this study, the expression of jhp0106 (with
a putative glycosyltransferase function) is under the control of the CsrA/RpoN system through the binding of RpoN to flaB promoter.
the complex regulatory pathways of flagella formation could in
the future lead to novel therapies against H. pylori colonization.
Future work will focus on the characterization of the Jhp0106
protein, including localization, enzymatic residues, and target
proteins.
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